VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Novo Nordisk A/S vs RTX Corporation
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisRTX Corporation
RTX · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into RTX Corporation's moat claims, evidence, and risks.
View RTX analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 69 / 100 for RTX Corporation).
- Segment focus: Novo Nordisk A/S has 3 segments (71.1% in Diabetes care); RTX Corporation has 3 segments (34.8% in Pratt & Whitney).
- Moat breadth: Novo Nordisk A/S has 5 moat types across 3 domains; RTX Corporation has 8 across 3.
Primary market context
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
RTX Corporation
Pratt & Whitney
Aircraft engines & aftermarket services (commercial and military)
Global
Airframers, airlines, governments
Engine OEM + MRO
34.8%
Side-by-side metrics
Moat coverage
Shared moat types
Novo Nordisk A/S strengths
RTX Corporation strengths
Segment mix
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
RTX Corporation segments
Full profile >Collins Aerospace
Oligopoly
Pratt & Whitney
Oligopoly
Raytheon
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.